Charles Schwab Investment Management Inc Alx Oncology Holdings Inc Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 133,433 shares of ALXO stock, worth $218,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,433

Previous 211,051 36.78%

Holding current value

$218,830

Previous $130,000 56.92%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$0.41 - $0.61 $31,823 - $47,346	-77,618 Reduced 36.78%	133,433 $56,000
Q1 2025 Sep 15, 2025	BUY	$0.62 - $1.86 $48,123 - $144,369	77,618 Added 58.17%	211,051 $130,000
Q1 2025 May 09, 2025	SELL	$0.62 - $1.86 $3,506 - $10,520	-5,656 Reduced 2.61%	211,051 $130,000
Q4 2024 Feb 06, 2025	SELL	$1.21 - $1.87 $10,399 - $16,072	-8,595 Reduced 3.81%	216,707 $361,000
Q3 2024 Nov 12, 2024	SELL	$1.81 - $8.13 $19,399 - $87,137	-10,718 Reduced 4.54%	225,302 $410,000
Q2 2024 Aug 12, 2024	BUY	$5.84 - $17.56 $153,364 - $461,143	26,261 Added 12.52%	236,020 $1.42 Million
Q1 2024 May 08, 2024	BUY	$10.95 - $16.79 $17,465 - $26,780	1,595 Added 0.77%	209,759 $2.34 Million
Q4 2023 Feb 06, 2024	BUY	$4.81 - $15.38 $324,338 - $1.04 Million	67,430 Added 47.91%	208,164 $3.1 Million
Q3 2023 Nov 08, 2023	SELL	$4.19 - $7.35 $103,983 - $182,404	-24,817 Reduced 14.99%	140,734 $675,000
Q2 2023 Aug 09, 2023	BUY	$4.37 - $9.56 $65,895 - $144,155	15,079 Added 10.02%	165,551 $1.24 Million
Q1 2023 May 11, 2023	SELL	$4.52 - $11.71 $42,998 - $111,397	-9,513 Reduced 5.95%	150,472 $680,000
Q4 2022 Feb 13, 2023	BUY	$9.51 - $12.95 $80,673 - $109,854	8,483 Added 5.6%	159,985 $1.8 Million
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $1,736 - $3,194	-211 Reduced 0.14%	151,502 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $107,398 - $354,833	18,234 Added 13.66%	151,713 $1.23 Million
Q1 2022 May 13, 2022	SELL	$13.65 - $22.06 $87,400 - $141,250	-6,403 Reduced 4.58%	133,479 $2.26 Million
Q4 2021 Feb 11, 2022	BUY	$21.49 - $74.4 $25,272 - $87,494	1,176 Added 0.85%	139,882 $3.01 Million
Q3 2021 Nov 16, 2021	BUY	$52.51 - $80.91 $2.42 Million - $3.72 Million	46,002 Added 49.62%	138,706 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $90,514 - $130,448	1,734 Added 1.91%	92,704 $5.07 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $1.19 Million - $1.66 Million	18,939 Added 26.29%	90,970 $6.71 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $481,189 - $1.58 Million	14,107 Added 24.35%	72,031 $6.21 Million
Q3 2020 Nov 13, 2020	BUY	$29.36 - $47.1 $1.7 Million - $2.73 Million	57,924 New	57,924 $2.19 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

31.6M

Call Options Held

53.8K

Put Options Held

11.7K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $66.8M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Alx Oncology Holdings Inc Transaction History